ltrasound-guided Acupotomy Treatment for Degenerative Cervical Radiculopathy

Not Applicable

• Conditions: Diseases of the musculoskeletal system and connective tissue

• Registration Number: KCT0009454
• Lead Sponsor: Pusan National University Korean Medicine Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

1) aged 30 years and older but younger than 75 years
2) pain or discomfort (numbness, paresthesia, muscle weakness) in the cervical spine and upper extremities = VAS 30mm
3) Symptom duration of 3 months or more
4) confirmed to have intervertebral disc herniation, stenosis, or spondylosis on imaging examination (CT or MRI)
5) Individuals who have received a final diagnosis of degenerative cervical radiculopathy based on comprehensive physical examination, medical history, and imaging examination results
6) Individuals who voluntarily decide to participate after being informed of the study purpose and procedure and provide written informed consent

Exclusion Criteria

1) History or current signs of myelopathy
2) Other spinal diseases or other medical conditions (e.g., thoracic outlet syndrome, carpal tunnel syndrome, plexopathy) that could cause similar symptoms to radiculopathy
3) History of cervical spine surgery or planned surgery during the study period
4) Serious medical history of cervical spine fracture, luxation, tumor, congenital abnormality
5) Infectious or non-infectious spondylitis (e.g., ankylosing spondylitis, rheumatoid arthritis)
6) Individuals taking anticoagulants or antiplatelet drugs, or with bleeding disorders that may affect hemostasis
7) History of receiving epidural injections, nerve blocks, or other injections within 2 months
8) Individuals with acupuncture hypersensitivity, metal allergies, severe atopic dermatitis, keloid skin, or other skin hypersensitivity
9) Individuals with significant neuropsychiatric medical history or current illness
10) Individuals with a history of alcoholism or drug abuse
11) Pregnant or lactating women or those planning to become pregnant
12) Individuals who are unable to self-report consent/data or require assistance from a caregiver/researcher to do so
13) Other individuals deemed inappropriate by the clinical research coordinator

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility

Secondary Outcome Measures

Name	Time	Method
Safety assessment (Adverse effect);Visual analog scale, Upper extremity pain/discomfort;Visual analog scale, Cervical pain;painDETECT;Neck Disability Index;Depression Anxiety Stress Scale-21 (DASS-21);Euroqol-5 Dimensions-5 Levels;Patient Global Impression of change (PGIC)